Acura Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Net Income	-0.88	-1.21	-3.77	-3.84	-5.68
Depreciation & Amortization	0.09	0.13	0.27	0.28	0.29
Other Amortization	-	-	0.07	0.09	0.1
Loss (Gain) From Sale of Assets	-	-	0	-	-0
Asset Writedown & Restructuring Costs	0.05	0.67	-	-	-
Stock-Based Compensation	0.06	0.04	0.11	0.22	0.46
Other Operating Activities	-0.54	-0.22	2.59	-0.47	0.05
Change in Accounts Receivable	0.47	-0.47	-0.02	-0.07	0.08
Change in Inventory	-	-	-	-	0.1
Change in Accounts Payable	0.16	-0.21	-0.37	0.6	-0.07
Change in Income Taxes	-	0.07	0.07	-	-0.14
Change in Other Net Operating Assets	-0.15	0.49	0.45	-0.72	0.29
Operating Cash Flow	-0.74	-0.72	-0.62	-3.91	-4.51
Other Investing Activities	-	-	-	-	0.31
Investing Cash Flow	-	-	-	-	0.31
Long-Term Debt Issued	0.42	0.27	1.38	4.35	-
Long-Term Debt Repaid	-0.02	-	-	-2.57	-2.76
Net Debt Issued (Repaid)	0.4	0.27	1.38	1.78	-2.76
Issuance of Common Stock	0	0	0.01	0	4
Repurchase of Common Stock	-0.01	-0	-	-	-
Financing Cash Flow	0.39	0.27	1.39	1.78	1.24
Net Cash Flow	-0.35	-0.45	0.77	-2.13	-2.96
Free Cash Flow	-0.74	-0.72	-0.62	-3.91	-4.51
Free Cash Flow Margin	-47.47%	-20.14%	-23.26%	-953.17%	-152.06%
Free Cash Flow Per Share	-0.01	-0.02	-0.02	-0.18	-0.28
Cash Interest Paid	-	-	-	0.76	0.36
Levered Free Cash Flow	-1.1	-0.33	-0.57	-2.62	0.96
Unlevered Free Cash Flow	-0.98	-0.04	-0.35	-2.46	1.24
Change in Working Capital	0.48	-0.12	0.12	-0.18	0.27

Source: S&P Global Market Intelligence. Standard template. Financial Sources.